Complete Genomics Closes $39M Funding Round, Vows to 'Vigorously Defend' Against Illumina Suit
August 24, 2010
Complete Genomics Closes $39M Funding Round, Vows to 'Vigorously Defend' Against Illumina Suit
The new round brings Complete Genomics' total financing since inception to $130 million. The company closed the financing as it prepares for an initial public offering in which it aims to raise up to $86.25 million.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- New Sequencing Platforms Drive Choice, Competition, Lawsuits in 2010
January 4, 2011 / In Sequence - Complete Genomics Nets $47M in IPO at $9 per Share
November 16, 2010 / In Sequence - Illumina Withdraws Complete Genomics Bid
January 8, 2013 / GenomeWeb Daily News - Clinical Genome Sequencing Requires Better Standards for Accuracy, Completeness, NHGRI Team Says
August 24, 2011 / Clinical Sequencing News - Complete Genomics Signs Two Contracts Worth $14M as Falling Prices Impact Q2 Revenues
August 9, 2011 / In Sequence